Evidence map›Paper›PMID 31104292›Full record

ArticleJournal of assisted reproduction and genetics2019

Comparison of daily vaginal progesterone gel plus weekly intramuscular progesterone with daily intramuscular progesterone for luteal phase support in single, autologous euploid frozen-thawed embryo transfers.

Mehmet Resit Asoglu, Cem Celik, Lale Susan Karakis, Necati Findikli, Meral Gultomruk, Mustafa Bahceci

Open access · bronzeAbstract read
In one paragraph

Article in Journal of assisted reproduction and genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Mehmet Resit AsogluBahceci Fulya Assisted Reproduction Center, Hakki Yeten St. No:11, Sisli, 34394, Istanbul, Turkey. mresitasoglu@hotmail.com.ORCID http://orcid.org/0000-0002-9232-8462
Cem CelikBahceci Umut Assisted Reproduction Center, Mahir Iz st. No: 31, Uskudar, 34662, Istanbul, Turkey.
Lale Susan KarakisBahceci Fulya Assisted Reproduction Center, Hakki Yeten St. No:11, Sisli, 34394, Istanbul, Turkey.
Necati FindikliBahceci Umut Assisted Reproduction Center, Mahir Iz st. No: 31, Uskudar, 34662, Istanbul, Turkey.
Meral GultomrukBahceci Fulya Assisted Reproduction Center, Hakki Yeten St. No:11, Sisli, 34394, Istanbul, Turkey.
Mustafa BahceciBahceci Fulya Assisted Reproduction Center, Hakki Yeten St. No:11, Sisli, 34394, Istanbul, Turkey.
Scientific and Technological Research Council of Turkey · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo compare outcomes between daily intramuscular progesterone (IMP) and daily vaginal progesterone (VP) gel plus weekly intramuscular hydroxyprogesterone caproate (IMHPC) for luteal phase support (LPS) in single, autologous euploid frozen-thawed blastocyst transfers (FBTs) following artificial endometrial preparation (EP).

methodsThe retrospective cohort study included 767 single, autologous FBTs from 731 patients between January 2015 and March 2018. LPS was performed either with IMP (100 mg/day) or with VP gel (90 mg, twice daily) plus IMHPC (250 mg/week). Oral estrogen was prescribed in combination of both regimes. Oral estrogen was discontinued following the visualization of fetal cardiac activity on ultrasound and progesterone at 10 weeks of gestation. The primary outcome was live birth rate. The secondary outcomes included implantation, clinical pregnancy, and multiple pregnancy rates.

resultsPatient characteristics did not differ in LPS regimes. Of 767 FBTs, 608 had IMP (100 mg/day) for LPS and 159 had VP gel (90 mg, twice daily) plus IMHPC (250 mg/week) for LPS. The live birth rate was 51.8% and 50.3%, respectively (p = 0.737, OR 0.94, 95%CI 0.66-1.33). The implantation rate was 62.7% and 64.2%, respectively (p = 0.730, OR 1.06, 95%CI 0.74-1.53). The clinical pregnancy rates were also similar in both groups (59.5% vs. 61.6%, respectively, p = 0.631, OR 1.09, 95%CI 0.76-1.56).

conclusionsWe did not observe significant differences in the rates of live birth, implantation, and clinical pregnancy between daily IMP and daily VP gel plus weekly IMHPC for LPS in single, autologous euploid FBTs after artificial EP.

Indexed as

Fertilization in VitroSingle Embryo TransferAdministration, IntravaginalAdultBlastocystCryopreservationEmbryo ImplantationFemaleGelsHumansInfertilityInjections, IntramuscularLuteal PhasePregnancyPregnancy RateProgesteroneCrinoneGelsProgesteroneEuploid frozen-thawed blastocyst transfersIntramuscular progesteroneLive birthLuteal phase supportVaginal progesterone gel

Identifiers

PMID31104292
PMCPMC6642241
OpenAlexW2945703981

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.